Aurobindo Pharma secures FDA approval for Fingolimod Capsules
In a significant development for the pharmaceutical industry, Aurobindo Pharma Limited has announced receiving the final nod from the United States Food and Drug Administration ... Read More
Mallinckrodt to acquire Sucampo Pharmaceuticals in $1.2bn deal
In a strategic move to broaden its pharmaceutical offerings, UK-based Mallinckrodt has announced the acquisition of Sucampo Pharmaceuticals, including its commercial and developmental assets, for ... Read More
Novartis to acquire Advanced Accelerator Applications for $3.9bn to enhance oncology portfolio
Novartis, the Switzerland-based global healthcare giant, has announced its decision to acquire Advanced Accelerator Applications (AAA), a French radiopharmaceutical company, for $3.9 billion. This acquisition ... Read More
Lupin expands US women’s health portfolio with $150m acquisition of Symbiomix Therapeutics
Lupin Limited, a Mumbai-based generics pharmaceutical company, has strategically broadened its foothold in the women’s health sector by acquiring Symbiomix Therapeutics. The acquisition, valued at ... Read More
FDA approves Novo Nordisk’s Victoza for cardiovascular disease treatment in type 2 diabetes patients
Novo Nordisk’s diabetes medication, Victoza (liraglutide), has gained U.S. Food and Drug Administration (FDA) approval for an expanded use, marking a significant step forward in ... Read More
Two dead, four injured in Vizag pharma city explosion
Vizag fire accident news : A fire accident at the Jawaharlal Nehru Pharma City near Visakhapatnam on Tuesday left two employees dead and four injured ... Read More
Sawai Pharmaceutical to acquire generic pharma business of Upsher-Smith
Japanese pharma company Sawai Pharmaceutical will acquire American generic drug maker Upsher‐Smith Laboratories’s generic pharma business for nearly $1.05bn from Acova. The generic drug portfolio ... Read More